Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis.
Seddon JA, Achar J, Malik AA, Hughes J, Burzynski J, Chen C, Denholm JT, Dravniece G, Fox GJ, Furin J, Geliukh E, Goncharova O, Guglielmetti L, Harries AD, Hesseling AC, Nguyen BH, Kavenga F, Khan U, Kherabi Y, Kiria N, Kock Y, Liu Q, Mesic A, Moore DAJ, Mubanga A, Naidoo L, Nilsen D, Piubello A, Reuter A, Rich ML, Satyanarayana S, Schaaf HS, Schoeman I, Skrahina A, Udwadia Z, Khan PY, Esmail H, Martinez L.
Seddon JA, et al. Among authors: burzynski j.
Lancet Infect Dis. 2025 Dec;25(12):e692-e704. doi: 10.1016/S1473-3099(25)00157-4. Epub 2025 Jun 6.
Lancet Infect Dis. 2025.
PMID: 41036784
Review.